Affimed (AFMD) Set to Announce Earnings on Tuesday

Affimed (NASDAQ:AFMD) will release its earnings data before the market opens on Tuesday, March 20th. Analysts expect Affimed to post earnings of ($0.19) per share for the quarter.

Affimed (NASDAQ:AFMD) traded up $0.02 during mid-day trading on Wednesday, hitting $2.22. 253,921 shares of the company’s stock were exchanged, compared to its average volume of 912,506. Affimed has a one year low of $1.15 and a one year high of $2.85. The company has a market cap of $126.39, a P/E ratio of -2.82 and a beta of 2.25. The company has a debt-to-equity ratio of 0.14, a current ratio of 6.43 and a quick ratio of 6.39.

Separately, Oppenheimer restated a “hold” rating on shares of Affimed in a research report on Friday, November 24th.

COPYRIGHT VIOLATION NOTICE: This news story was published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The legal version of this news story can be viewed at

About Affimed

Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company’s product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body’s own immune system to fight tumor cells.

Earnings History for Affimed (NASDAQ:AFMD)

Receive News & Ratings for Affimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affimed and related companies with's FREE daily email newsletter.

Leave a Reply